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Abstract
Introduction
Xanthine oxidase (XO) is distributed in mammals largely in the liver and small intestine, but
also is highly active in milk where it generates hydrogen peroxide (H2O2). Adult human
saliva is low in hypoxanthine and xanthine, the substrates of XO, and high in the lactoperox-
idase substrate thiocyanate, but saliva of neonates has not been examined.
Results
Median concentrations of hypoxanthine and xanthine in neonatal saliva (27 and 19 μM
respectively) were ten-fold higher than in adult saliva (2.1 and 1.7 μM). Fresh breastmilk
contained 27.3±12.2 μMH2O2 but mixing baby saliva with breastmilk additionally generated
>40 μMH2O2, sufficient to inhibit growth of the opportunistic pathogens Staphylococcus
aureus and Salmonella spp. Oral peroxidase activity in neonatal saliva was variable but low
(median 7 U/L, range 2–449) compared to adults (620 U/L, 48–1348), while peroxidase sub-
strate thiocyanate in neonatal saliva was surprisingly high. Baby but not adult saliva also
contained nucleosides and nucleobases that encouraged growth of the commensal bacte-
ria Lactobacillus, but inhibited opportunistic pathogens; these nucleosides/bases may also
promote growth of immature gut cells. Transition from neonatal to adult saliva pattern
occurred during the weaning period. A survey of saliva from domesticated mammals
revealed wide variation in nucleoside/base patterns.
Discussion and Conclusion
During breast-feeding, baby saliva reacts with breastmilk to produce reactive oxygen spe-
cies, while simultaneously providing growth-promoting nucleotide precursors. Milk thus
plays more than a simply nutritional role in mammals, interacting with infant saliva to
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produce a potent combination of stimulatory and inhibitory metabolites that regulate early
oral–and hence gut–microbiota. Consequently, milk-saliva mixing appears to represent
unique biochemical synergism which boosts early innate immunity.
Introduction
Nucleotides play an essential role in many cellular processes involving biosynthesis, energy
supply, DNA and RNA synthesis, essential coenzymes, and regulatory mechanisms. They are
synthesised in cells by de novo pathways, which are energy-consuming, and recycle by salvage
pathways, which conserve cellular energy. While some bacteria synthesise their nucleotides de
novo, all known microbiota are able to recycle their nucleotides. Some bacteria, including lactic
acid bacteria (e.g. Lactococcus lactis) readily salvage external sources of purine/pyrimidine
nucleosides/bases as precursors for nucleotide synthesis, to positively select for their growth in
synthetic media [1,2]. Understanding the selection processes acting on the oral microbial com-
munity during human infancy may assist with development of strategies to subsequently main-
tain healthy gut microbiota.
Xanthine oxidase (XO) has been the focus of considerable research into ischemia reperfu-
sion injury [3,4], however, there is increasing evidence that XO has positive physiological func-
tions associated with the production of antibacterial reactive oxygen species (ROS) and
reactive nitrogen species (RNS) [5]. XO activity has been found in the milk of all mammals
studied [6], with higher activity in bovine milk than human milk [7]. XO is a major protein
component of the milk fat globule membrane surrounding the fat droplets that form a suspen-
sion in freshly-expressed milk [8]. In the presence of its biochemical substrates (hypoxanthine
or xanthine), XO produces microbiocidal superoxide and hydrogen peroxide (H2O2).
H2O2 subsequently acts as a substrate for the milk enzyme lactoperoxidase (LPO) present in
both milk and saliva to convert–for example–dietary thiocyanate into the antibacterial ROS
hypothiocyanate. The primary role of XO is thus considered to be antimicrobial, in both the
milk glands (to prevent mastitis) and the milk (to reduce bacterial load) [9], acting in combina-
tion with milk LPO in milk: this is known as the 'LPO system' [10,11]. XO has also been shown
to catalyse the anaerobic reduction of inorganic nitrite to nitric oxide [12,13]. Superoxide gen-
erated by XO in the presence of molecular oxygen reacts rapidly with nitric oxide to yield the
RNS peroxynitrite, a powerful antibacterial agent [14,15]. Importantly, the LPO mechanism
relies for its activation on the presence of XO substrates.
We discovered substantially raised concentrations of xanthine and hypoxanthine in neona-
tal saliva and proposed that these two substrates should react with milk XO during breast-feed-
ing to produce H2O2. We then asked: Is the amount of H2O2 produced during breast-feeding
sufficient to activate the LPO system and produce microbial inhibition? Combined with
increased concentrations of growth-stimulating nucleotide precursors also found in neonatal
saliva, we investigated whether there may be a unique metabolic relationship between infant
and mother during the breast-feeding period to regulate oral–and hence gut–microbiota, and
consequently enhance the innate immunity of the neonate.
Results
Among 77 adults that we screened, we found low or undetectable concentrations of nucleotide
metabolites (excluding urate) except in 9 adults (Fig 1A). One adult had an anomalously high
inosine, while eight subjects had mildly raised xanthine/hypoxanthine (the substrates of XO).
Breastmilk-Neonatal Saliva Interactions
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The demographic parameters of 60 neonates are shown in Table 1. Among the neonates,
median concentrations of salivary hypoxanthine and xanthine were ten-fold higher (27 μM
and 19 μM respectively) than median adult values (2.1 and 1.7 μM respectively) (p<0.05) (Fig
1B). Interestingly, while some nucleosides and bases were raised in the neonates, others such as
pseudouridine, thymine and dihydrothymine were always low, while deoxy-nucleosides were
undetectable. The pyrimidine base orotic acid was interesting: although the median concentra-
tions were less than 1 μM for most adults and neonates, several neonatal saliva samples
exceeded 10 μM orotic acid.
Fig 1. Concentration of nucleotide precursors in whole saliva samples of human adults, term neonates, and domesticated mammals. (A) Healthy
non-smoking adults (n = 77) and (B) healthy full-term vaginally-delivered neonates (n = 60), lines showmedian values. Non-parametric analyses were
conducted to estimate the significance using a Mann-Whitney U test, (C) Longitudinal study of median concentrations of metabolites in saliva from full-term
neonates aged 1–4 days (n = 60), 6 weeks (n = 20), 6 months (n = 19), and 12 months (n = 14), (D) Median metabolite concentrations in saliva from selected
domesticated mammals (8 cows, 5 sheep, 4 goats, 5 horses, 1 camel, 7 dogs, 5 cats). Metabolites were divided into five functional groups: Pyrimidines
(Pseudouridine to Orotate); Purine bases (Hypoxanthine, Xanthine); Purine nucleosides (Inosine, Guanosine); ATP precursors (Adenine, Adenosine);
Deoxynucleosides (Deoxyadenosine to Deoxyuridine).
doi:10.1371/journal.pone.0135047.g001
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To gain insights into the transitioning of these purine and pyrimidine metabolites in saliva
from the high levels seen in the infants to the low levels of the adult pattern, we conducted a
12-month longitudinal study of 14 breast-fed infants. All metabolites reached the adult level
after weaning, but there were differences in patterns. The purine metabolites hypoxanthine,
xanthine, adenosine, inosine and guanosine gradually decreased to adult levels between 6–12
months of age, while in contrast, the pyrimidine metabolites uracil and uridine decreased
sharply to adult levels by 6 weeks of age (Fig 1C).
To assess whether the human salivary pattern of nucleotide metabolites was unique, we ana-
lysed the patterns of purines and pyrimidines in salivas from a selection of mature domesti-
cated mammals. Distinctive inter-species differences emerged that far exceeded any inter-
individual differences (Fig 1D). Details of the data are shown in S1 Table. Similar to humans,
salivary deoxy-nucleosides were generally negligible in most species, except horse saliva, which
uniquely contained raised levels of deoxy-uridine, deoxy-inosine, deoxy-thymidine and deoxy-
guanosine. But in contrast to human adults, all of the adult mammals had raised levels of nucle-
otide metabolites, with uracil being the most prevalent metabolite, the highest concentration in
horse saliva (median 80.5 μM).
In view of the unexpected presence of high levels of xanthine and hypoxanthine in human
neonatal saliva, we formed a hypothesis that this phenomenon must be linked to the presence
of high activity XO in mammalian milk. We assayed the in situ XO activity–localised within
the milk fat globule membranes–of 24 breastmilk samples found a mean of 8.0±5.3 U/L (appar-
ent Km = 12.8±2.1 μM, and apparent Vmax = 8.9±6.2 μmol/min) (Fig 2A). We could not detect
any XO activity in pasteurised breastmilk, and not in infant dried-milk formula nor in pasteur-
ised bovine milk, demonstrating that milk XO is inactive by commercial heat-pasteurisation.
H2O2 production by breastmilk was inhibited by oxypurinol (an XO-specific inhibitor) (Fig
2B) in a dose-dependent manner, complete inhibition being achieved with 12 μM oxypurinol
(apparent Ki = 0.6 μM), confirming that the role of XO activity in H2O2 generation.
Freshly expressed milk contains H2O2 made by XO in the milk gland lumen. We deter-
mined the mean endogenous H2O2 concentration in 24 fresh breastmilk samples to be 27.3
±12.2 μM (Fig 2C). When breastmilk was mixed with a neonatal saliva (containing endoge-
nous 30 μM xanthine and 70 μM hypoxanthine), the interaction yielded an additional 40 μM
H2O2 during a 1 h incubation (Fig 2D).
Salivary peroxidase (SPO) is present in adult saliva, but we found that the distribution of
neonatal SPO activity was highly variable and non-parametric, mostly being low to negligible
with just a few samples having activity in the adult range (median 7 U/L, range 2–449, n = 12),
Table 1. Physical information of the participating neonates.
Male Female Total p value
N 22 38 60 n.s.
Gestational age (weeks)
Mean±SD 40±1.4 40±1.3 40±1.3 0.5 (n.s.)
Range 38–42 37–42 37–42
Birth weight (g)
Mean±SD 3751±467 3665±435 3697±445 0.5 (n.s.)
Range 2630–4685 2768–4446 2630–4685
Age (hours)
Mean±SD 34±14 34±16 34±14 0.9 (n.s.)
Range 8–62 8–80 8–80
doi:10.1371/journal.pone.0135047.t001
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while the distribution of SPO activity in adults was parametric (median 620 U/L, 48–1348,
n = 12). Breastmilk LPO activity, which ranged from 4–90 U/L (n = 14), was relatively low
compared to adult SPO but similar to neonatal SPO. Thiocyanate is considered to be an impor-
tant peroxidase substrate. In neonate saliva the median concentration was 0.42 mM (with a
wide range of 0.08–3.20 mM), then it declined over the weaning period before rising again to
an adult median of 1.38 mM (0.45–5.82 mM) (Fig 3), these medians differing significantly
(p = 0.0015).
We then tested the effects on in vitro growth of four bacterial species by micromolar con-
centrations of H2O2 in standard nutrient growth media. Our results demonstrated a remark-
able sensitivity of the opportunistic pathogen (Gram-positive) Staphylococcus aureus to H2O2
in the range of 25–100 μM, while growth of Gram-negative opportunistic pathogen Salmonella
Fig 2. Breastmilk XO generates H2O2 when interacted with neonatal saliva. (A) Distribution of XO activity in breastmilk. Samples of colostrum were
collected 1–5 day postpartum (n = 24). Error bars showmean±SD. XO activity was 8.0 ± 5.3 U/L. (B) Dose dependent inhibition of breastmilk XO by
oxypurinol. Pooled breastmilk samples containing 0–25 μM oxypurinol concentrations (n = 3) were incubated with the peroxidase reagent containing 400 uM
hypoxanthine. (C) The mean concentration of H2O2 in fresh breastmilk samples (n = 22) was 27.3±12.2 μM. (D) Kinetics of H2O2 generation after mixing
33 μL of diluted breastmilk, 33 μL of 1/3 diluted neonatal saliva and 34 μL peroxidase assay working solution (green circles). The negative control was buffer
and peroxidase reagents (blue squares), (n = 2). The original concentrations of hypoxanthine and xanthine in the neonatal saliva were 70 μM and 30 μM
respectively. Calculation of [H2O2] was based on two-fold dilutions assuming that breastmilk and neonatal saliva is 1:1 during suckling (1 mole xanthine
produces 1 mole H2O2, 1 mole hypoxanthine generates 2 moles H2O2).
doi:10.1371/journal.pone.0135047.g002
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spp, the commensal (Gram-positive) Lactobacillus plantarum and gut commensal (Gram-neg-
ative) Escherichia coli were not affected until the H2O2 concentration exceeded 100 μM (Fig 4).
To demonstrate inhibition of bacterial growth under physiological conditions emulating
breast-feeding, we then studied the viability of these bacteria in a medium comprising breast-
milk mixed with ‘simulated neonatal saliva’ supplemented with serial dilutions of hypoxan-
thine and xanthine, which potentially generated 18–150 μMH2O2 and activated the milk LPO
system. The breastmilk-saliva mixture inhibited, in a dose-dependent manner, the viability of
S. aureus, Salmonella spp and L. plantarum, whereas E. coli was unaffected (Fig 5A).
We also tested the effects on these four bacterial species of breastmilk and 'simulated neona-
tal saliva' supplemented with nucleotide metabolites, and observed marked differences in
growth response between the bacteria (Table 2). Supplementation of a breastmilk-saliva mix-
ture with these purine/pyrimidine nucleosides and bases–but excluding the XO substrates
hypoxanthine and xanthine–increased the count (CFU/mL) of L. plantarum by about 50%,
although this increase did not reach significance, while S. aureus, Salmonella spp, and E.coli
showed no overall increase in counts with the experimental mixture (Fig 5B). When hypoxan-
thine and xanthine (which activate XO) were included in the metabolite mix to recreate a typi-
cal neonatal saliva profile, the counts of S. aureus and Salmonella spp. were significantly
decreased and the improved response of L. plantarum was negated, while there continued to be
no response by E. coli. When oxypurinol was added–to prevent XO generation of H2O2 –the
loss of S. aureus, Salmonella spp. and L. plantarum was reversed.
Discussion
Nucleotide Metabolites in Neonatal Saliva
In an exploration of the physiological role of neonatal salivary nucleotide precursors, we seren-
dipitously discovered a biochemical mechanism that may be an important factor in the
improved health outcomes observed with breast-feeding: maternal milk interacts with the
saliva of the neonate during suckling, producing peroxide. An in vitromodel for regulation of
Fig 3. Thiocyanate in saliva.Median concentrations and interquartile ranges (mM) of thiocyanate (SCN-) in
saliva of neonates (n = 16), infants at 6 weeks (n = 16), 6 months (n = 18), and 12 months (n = 12), and adults
(n = 20).
doi:10.1371/journal.pone.0135047.g003
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bacteria present in the neonate’s oral microbiota demonstrated a significant and discriminatory
effect on the growth of these bacteria. Regulation of the oral microbiota of neonates is impor-
tant for their subsequent health, because the gut is colonised by bacteria from the mouth. A
recent review [16] reports early colonisation of the fetal gut by bacteria via swallowing in utero;
the fetus becomes further colonised by bacteria from the placental microbiome [17]. The pla-
cental microbiome is very similar to the human oral microbiome and the full-term neonatal
gut microbiome; colonised largely by Actinobacteria, Proteobacteria, Bacteroidetes and Firmi-
cutes. Post-natally, the exposure of the infant to the mother's skin microbiota during breast-
feeding also influences the gut microbiota. Thus the range of oral microbial species that the
infant is exposed to orally, and any subsequent selection among those species, determines the
establishment of the gut microbiome [16].
Only one group of workers have studied salivary nucleotide metabolites, reporting low con-
centrations (1–5 μM) of inosine, xanthine and hypoxanthine in adult saliva [18]. In plasma,
nucleotide metabolite concentrations are usually less than 1 μM, with the exception of uric acid
and uridine [19,20]. We confirmed these residual levels of purine/pyrimidine nucleosides and
bases in adult saliva, although several adults exhibited salivary patterns that carried echoes of
the neonatal pattern–a variance that may arise from genetic polymorphism in the population,
for example, of nucleoside transporters. We demonstrated that the neonatal salivary pattern
evolved into the adult pattern over a period between 6 weeks and 6 months, with an apparent
difference between purines and pyrimidines. Such an early transition was unexpected but in
retrospect this appears to confirm a link between the neonatal pattern and weaning.
Fig 4. Effect of H2O2 on bacterial growth. The effect of increasing H2O2 concentration (0–400 μM) on bacterial growth. Hydrogen peroxide was added to
nutrient broth inoculated with bacteria and incubated for 24 h at 37°C, except for L. plantarum, which was incubated for 48 h. The concentration of cells was
determined as turbidity by measuring absorbance at 600 nm. Values represent the mean±SD (n = 3).
doi:10.1371/journal.pone.0135047.g004
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We could exclude dental flora, pathological conditions and neonatal stress as the cause of
raised salivary metabolite concentrations in neonates, which suggests that specific transport
mechanisms may be active in the salivary glands of neonates. We have pointed out that salivary
hypoxanthine and xanthine can stimulate peroxide production via XO, thus activating the
‘LPO system’. Other salivary nucleosides and bases can be readily utilised by the nucleotide sal-
vage pathways in heterotrophic oral bacteria [1], or when nucleosides/bases are swallowed in
Fig 5. Salivary nucleotide metabolites and XO regulate bacterial growth. Bacteria were incubated with breast milk and simulated neonatal saliva for 24 h
at 37°C and then enumerated by sub-culturing onto agar plates. Values represent the mean±SD (n = 3). (A) Bactericidal effects of H2O2 generated by
breastmilk (XO) and increasing concentrations of salivary xanthine and hypoxanthine (0–50 μM). Figure displays the concentration-dependent effect of
xanthine and hypoxanthine versus log CFU/mL. ANOVA was used to compare between multiple means. (B) The effect of breastmilk plus simulated neonatal
saliva (with and without supplements) on bacterial counts (CFU/mL). Bacteria were incubated with breastmilk and saliva alone (Control), or supplemented
with nucleotide metabolites omitting xanthine/hypoxanthine (Full supplement except X&HX), or the latter with xanthine/hypoxanthine (Full supplement), or
the latter with oxypurinol (Full supplement + Oxypurinol) (see Table 2). Means were compared by t-test: * p<0.05; ** p<0.01; ns, not significant.
doi:10.1371/journal.pone.0135047.g005
Table 2. Supplemented saliva. Four 'simulated neonatal saliva' formulations were used to evaluate in vitro
the bactericidal activity of mixtures of breast milk and simulated neonatal saliva. Saliva was collected from
adults, heat-inactivated, sterilised by filtration, then supplemented with bases and/or nucleosides. The saliva
concentrations of hypoxanthine (HX), xanthine (X), inosine, adenosine, guanosine, uracil and uridine were
27, 20, 11, 12, 7, 5.3 and 12 μM respectively.
Saliva Supplements
Control No supplements
Full supplement except
X&HX
inosine, adenosine, guanosine, uracil, uridine
Full supplement hypoxanthine, xanthine, inosine, adenosine, guanosine, uracil, uridine
Full supplement
+ oxypurinol
hypoxanthine, xanthine, inosine, adenosine, guanosine, uracil, uridine, plus
oxypurinol (100 μM)
doi:10.1371/journal.pone.0135047.t002
Breastmilk-Neonatal Saliva Interactions
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saliva they can be salvaged by gut apical cells to form nucleotides: it has been reported that rap-
idly growing tissues including intestinal epithelium cells lack significant capacity for de novo
synthesis of nucleotides and require exogenous sources of purine and pyrimidine bases and
nucleosides [21].
In the case of the nucleobase uracil, which was grossly raised in the saliva of human neo-
nates and the animals surveyed, mammalian cells cannot salvage this to form pyrimidine
nucleotides, but uracil can be utilised by commensal bacteria [2]. Similarly, deoxy-nucleosides
are generally not salvaged by mammalian cells, but uniquely horse saliva contained 10–20 μM
deoxy-nucleosides, which were low or undetectable in most of the other mammals, perhaps
pointing towards a specific role for uptake of deoxy-nucleosides by oral or gut bacteria in
horses. This demonstrated that species-specific mechanisms for nucleotide salvage exist. These
differences in saliva are echoed in milk itself where, for example, bovine milk has high concen-
trations of orotic acid [22] as a source of pyrimidine for suckling calves, whereas human milk
does not contain orotic acid but uridine as the pyrimidine source for neonates [23]. Interest-
ingly, the raised orotic acid that we observed in several neonatal salivas was able to be corre-
lated with bottle-feeding of the neonates with formula (bovine) milk.
Breastmilk Xanthine Oxidase Activity and Kinetic Parameters
Our kinetic studies of breastmilk XO in situ within milk fat globules found an apparent Km for
hypoxanthine of 12.8 ± 2.1 μM, which was comparable with published values for the purified
enzyme with hypoxanthine (Km = 8 μM) [24] or xanthine (Km = 18 μM) [25] as substrate.
The dose-dependent inhibition of H2O2 formation in breastmilk treated with oxypurinol
was consistent with its action as a specific inhibitor of XO [26], and confirmed that XO was
responsible for the H2O2 production observed for the peroxidase assay. This was important for
the design and interpretation of subsequent studies of bacterial inhibition by milk-saliva mix-
tures. Within the liver and small intestine, the major sites for xanthine oxidoreductase activity
in mammals (aside from milk), the enzyme is in the form of xanthine dehydrogenase (XDH),
however extracellular xanthine oxidoreductase is thought to exist solely as XO, e.g. cellular
XDH is transformed to plasma XO by serum proteases while in other tissues the transforma-
tion is thought to be the result of oxidation of critical amino acids within the enzyme. Milk
contains high amounts of proteases [27], and it has been suggested that these may be responsi-
ble for XO as the dominant form in milk [10].
Absence of Xanthine Oxidase Activity in Infant Formula and Pasteurised
Milk
Perhaps unsurprisingly, XO activity was undetectable in infant milk formula, indicating that
the preparation, processing and manufacturing of milk formula (from bovine milk) leads to
complete loss of the enzyme activity, which means that formula-fed babies do not experience
oral H2O2 generation nor the LPO system.
Similarly, XO activity was not detected in pasteurised breastmilk. Pasteurised human milk
has been developed specifically for babies whose mothers are unable to breast feed for medical
or other reasons, as breastmilk is considered more 'natural' and possibly less allergenic than
bovine milk. However, the status of XO activity in this product was previously unknown, but
our findings were consistent with previous reports of significant activity loss of essential
enzymes and proteins such as lysozyme [28,29], LPO, secretory IgA and lactoferrin [28] follow-
ing thermal pasteurisation of breastmilk. Several studies have shown that human milk thermal
pasteurisation also induced a significant loss of bactericidal capacity against E. coli [30], or
both E. coli and S. aureus [31].
Breastmilk-Neonatal Saliva Interactions
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Hydrogen Peroxide in Breastmilk
We found a mean H2O2 concentration of 27 μM in breastmilk, which was highly consistent
with a published value of 25 μM for first-week breastmilk samples [32]. The presence of H2O2
in fresh bovine milk has been proposed to arise from the co-secretion of XO substrates xan-
thine and hypoxanthine into the mammary gland lumen during continuous milk production
[9,10]. This continuous generation of H2O2 within the lumen is thought to be bactericidal,
which may protect the breast against mastitis–most frequently caused by S. aureus [33,34].
H2O2 in breastmilk has been reported to peak in the first few weeks after birth, then declining
to about 9 μM by the fourth week of infant life: this decline in H2O2 concentration postpartum
[32] is coincident with the reported decrease in milk XO activity during the same period [35].
Significantly, this also coincides with the decline of salivary hypoxanthine and xanthine in the
infant. In addition to direct inhibition of bacterial growth, H2O2 generated in breastmilk is also
thought to serve as a substrate for the LPO expressed in human milk, producing bactericidal
oxidative products [36]. This complex system may thus provide mammary glands with passive
protection against invading bacteria.
Hydrogen peroxide and other ROS and RNS may also play important roles as small-mole-
cule second messengers. It has been demonstrated that low concentrations of H2O2, in particu-
lar around 20 μM, stimulate cell viability and facilitates adhesion, migration, and wound
healing in cornea cells [37] as well as enhancing the production of T-cell growth factor inter-
leukin-2 [38]. This is consistent with a mechanism that generation of H2O2, as measured in
this study, may not only contribute to the innate immunity of neonates, but may provide the
appropriate concentrations for rapid cell signalling and growth of, for example, gut cells.
Generation of Hydrogen Peroxide in the Neonatal Mouth
We demonstrated that mixing neonatal saliva (which contains high levels of xanthine and
hypoxanthine), with breastmilk led to stimulation of H2O2 production. It can be speculated
that a similar mechanism occurs during breast-feeding, especially as the median levels of xan-
thine (19 μM) and hypoxanthine (27 μM) in neonatal saliva are higher than the Km values of
breastmilk XO for these two substrates.
The saliva that we used for the mixing experiment contained (median concentrations of)
70 μM hypoxanthine and 30 μM xanthine, then diluted with an equal volume of milk. Given
that a mole of hypoxanthine or xanthine produces 2 moles or 1 mole of peroxide respectively
when reacted with XO, the theoretical concentration of H2O2 produced by two-fold diluted
saliva should have been 85 μM (i.e. 70+15 μM). However, we observed only 40 μMH2O2,
which demonstrated competing consumption of H2O2, presumably by SPO and milk LPO
[39]. We found high variability of SPO activity in neonate saliva–a phenomenon noted previ-
ously by Gothefors and Marklund (1975) [39]–in contrast to adults who had more consistently
high activity of SPO with a mean similar to that of 750 μmol/min/L (U/L) reported by Haukioja
and co-workers (2004) [40]. Interestingly, the affinity (Km = 55 μM) of LPO towards H2O2 is
theoretically lower [41] than glutathione peroxidase (Km = 28 μM) [42], and this may have a
role in adult saliva, whereas the millimolar affinity of catalase suggests that this enzyme has no
role in catabolising H2O2 in normal saliva. The biological role of SPO in adult saliva is consid-
ered to be the breakdown of H2O2 produced by dental microflora, simultaneously protecting
teeth and producing antibacterial hypothiocyanate from thiocyanate; it has been demonstrated
that the major form of enzymatic H2O2 consumption in normal human tracheal secretions is
due to SPO [43]. In contrast, neonates have no need for protection against tooth decay, so SPO
activity is generally low [39], whereas maintenance of the neonate's innate immune system and
Breastmilk-Neonatal Saliva Interactions
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early shaping of the 'social structure' of its oral and gut microbiota [44] may be more dependent
upon the milk XO-LPO system.
Compared to later stages of infancy, we found the mean concentration (400 μM) of the perox-
idase substrate thiocyanate was relatively high in neonatal saliva, in agreement with a previous
study [39]. The concentration of thiocyanate in adults is dependant on dietary and smoking hab-
its, with saliva thiocyanate in non-smokers ranging between 500–2000 μM but reaching 6000 μM
in cigarette smokers due to absorption of cyanide in smoke [45]. The raised thiocyanate in new-
born saliva presumably derived frommaternal thiocyanate carrying over into the neonate, and
this then declined over 12 months. This was similar to our observation of high urate in neonatal
saliva that subsequently decreased (not shown). Thiocyanate derives primarily from dietary cru-
cifers–the cabbage/sprout family–so that the maternal plasma levels and hence neonatal saliva
are dependent upon the mother's diet. It can be assumed that the infant obtains some thiocyanate
from breastmilk–although this is relatively low [39]–but upon weaning, young children tend to
avoid thiocyanate-rich foods because of the bitter taste, so that thiocyanate levels in infant saliva
fall, until the crucifers gradually enter the diet and thiocyanate rises towards adult levels.
Hydrogen Peroxide Effects on Bacterial Growth in Nutrient Growth
Medium
H2O2 has been used for over a century to sterilise surfaces and cleanse wounds of bacterial inva-
sion, however, the concentrations that have been typically studied and used are 3–6% v/v H2O2,
or about 1–2 mol/L. Our approach was to initially examine whether micromolar concentrations
of H2O2 alone–in the absence of the XO/LPO system–would inhibit or stimulate bacterial
growth. We used a turbidity assay to assess in vitro bacterial growth in standard nutrient growth
medium supplemented with micromolar concentrations of H2O2. The results demonstrated a
remarkable inhibition of the Gram-positive S. aureus by 25–100 μMH2O2, while the growth of
Gram-negative Salmonella spp., the oral Gram-positive commensal Lactobacillus spp. and the
gut Gram-negative commensal Escherichia coli were not affected by H2O2 over this low range.
These results were remarkably similar to those of Thomas and co-workers (1994) who reported
that micromolar concentrations of H2O2 inhibited growth of oral Streptococcus [46].
Bacterial Growth in Breastmilk-Saliva Mixtures
Having demonstrated direct inhibition of S. aureus growth by micromolar H2O2, we then
developed a more physiological assay, where the H2O2 was generated by XO through the inter-
action between saliva and breastmilk in vitro. This system thus also included the milk/saliva
LPO system, as well as endogenous thiocyanate and other ions present in saliva. It has previ-
ously been demonstrated that addition of 100 μM hypoxanthine to milk boosts production of
H2O2 and nitric oxide (which can produce microbicidal peroxynitrite), completely abolishing
bacterial overgrowth in milk for at least 7 days [47].
Xanthine and hypoxanthine supplementation of the saliva-milk media to activate milk
XO/LPO significantly inhibited the growth of S. aureus compared to the control and nucleo-
side-supplemented saliva. Inhibition of XO by oxypurinol restored normal growth, demon-
strating the sensitivity of S. aureus to both direct peroxide addition and the XO-LPO system.
The response of Salmonella spp. to saliva-milk plus was similar to S. aureus, however Salmo-
nella spp. required>200 μM of direct H2O2 addition to inhibit growth. This illustrated a differ-
ence between simple titration with peroxide when compared to the presence of the XO-LPO
system, where other oxidative products are present. The growth of L. plantarum was noticeably
inhibited by activation of the LPO system by XO substrates, with oxypurinol restoring growth
to the level of the supplemented saliva. This mechanism had no effect on E.coli. Our results
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thus showed that the LPO system provided a negative selective mechanism for oral microbial
growth, especially during breast-feeding when saliva provided hypoxanthine and xanthine as
well as thiocyanate to activate the system. This is in accord with Thomas and co-workers
(1994), who found that inhibition of oral Streptococcus growth by SPO was potentially far more
effective than H2O2 alone [46]. The demonstration of this same effect on Helicobacter pylori is
further evidence that this oral system is part of a primal mechanism for defence against patho-
gens and perhaps regulation of commensal bacteria [40].
We then evaluated bacterial growth stimulation by the nucleosides and bases that we found
to be present in neonatal saliva (added at average concentrations and excluding xanthine/hypo-
xanthine). The growth of S. aureus, Salmonella spp., and E. coli did not benefit from supple-
mentation when compared to the non-supplemented control, whereas L. plantarum growth
was stimulated by supplemented saliva. Despite the fact that this did not reach statistical signif-
icance compared to the control, we regard this as an exciting focus for further study, because
previously published methods to measure growth stimulation with nucleoside supplementation
have used standard nutrient growth media that contain high (non-physiological) concentra-
tions of purine and pyrimidine metabolites; consequently this may have confounded the
results. Our method was designed to mimic the physiological conditions of a breast-feeding
infant's mouth, including an intact LPO system. Some brands of milk formulae are now supple-
mented with 'nucleotides' or perhaps nucleotide metabolites, but there remain important dif-
ferences between bovine milk and human milk, particularly in the pyrimidine composition: as
cow milk provides its pyrimidine in the form of orotate whereas breastmilk does not contain
orotate but provides uridine instead. Presumably these species differences have evolved from
specific requirements of either the oral microbiota and/or the immature gut cells in the young
mammals. Bovine milk infant formulae and breastmilk also differ in oligosaccharide content,
which appears to encourage growth of certain gut microbes: thus determination of the infant
microbiome becomes a delicate interplay of selective factors [48].
The presence in neonatal saliva of nucleosides is intriguing. We thus suggest that the bases
and nucleosides elevated in neonatal saliva may have roles as precursors for nucleotides. These
are known to promote the growth of commensal bacteria [1,2], but this may have wider impli-
cations for the development of neonatal gut cells (which take up nucleosides), and thus for the
mucosal immune system [49].
It has been shown in bovine calves that the LPO system is effective in preventing ‘scours’
(diarrhoea) [50,51]. During the supportive treatment of early preterm babies in hospital neonatal
intensive care units, feeding with expressed breastmilk, which has been pasteurised and lacks the
LPO system, is achieved by nasogastric intubation that by-passes saliva interaction. This proce-
dure unfortunately prevents the saliva-breastmilk effect described here, and may be an unrecog-
nised factor contributing to the risk of necrotising enterocolitis [52]. In addition, the absence of
the LPO system in infant milk formulae may be detrimental to the health of newborns by chang-
ing the selective processes that act on oral microbiota. Our studies point to an interplay of infant
saliva, containing hypoxanthine and xanthine as well as growth-promoting nucleotide precur-
sors, with the breastmilk XO-LPO system, producing positive and negative selective pressures on
the early oral microbiota that will colonise the gut in infants. This appears to be a unique bio-
chemical synergism within the milk-feeding phenomenon that defines mammals.
Materials and Methods
Human Saliva Samples
Study protocols received prior written approval from the Human Research Ethics Committees
(HREC) of Mater Health Services (MHS) and The University of Queensland (UQ), with
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informed consent. The study of regulation of oral microflora by interaction of salivary metabo-
lites with breastmilk was permitted by MHS HREC Study Reference Number 2012_01LNR.
The protocol for the study of adult saliva was permitted by MHS and UQ HRECs, Study Refer-
ence Numbers 1652M and 2011000388 respectively, with written informed consent from saliva
donors. The permission for the collection of infant salivas including the longitudinal study was
permitted by MHS and UQ HRECs, Study Reference Numbers 1651M and 2011000387 respec-
tively, with written informed consent being provided by the mothers for the collection of saliva
from their infants. Saliva collection from infants and adults was considered to have 'minimal'
risk of harm–in fact we found that none of the infants showed any distress during collection of
saliva using soft cotton swabs ('cotton buds'), which required about 30 sec. Analyses of saliva
samples, as well as the validation of analysis and limit of detection of salivary nucleotide metab-
olites using HPLC-tandem mass spectrometry (LC-MS/MS) were conducted as previously
described [53]. Samples were collected from vaginally-delivered, full-term neonates identified
as Caucasian. As part of ethical requirements, acceptable statistical power for the saliva studies
required 53 participants: this was increased to n = 60 for neonates and n = 77 for adults. Of the
60 neonates studied, the parents of 20 of them agreed for their infants to participate in a longi-
tudinal study involving follow-up sampling at 6 weeks (n = 20), 6 months (n = 19), and 12
months (n = 14) after the initial collection.
Other Mammalian Saliva Samples
Mature domesticated and farm mammals were chosen. Selection was based essentially on a
rationale relating to diet (which may be reflected by oral microbiota) and digestive tract: cat:
obligatory carnivore; dog: omnivore; horse, cow, sheep, goat and camel: herbivores; cows,
sheep and goats are ruminants; horses have pre-ruminant sacculation; camels are pseudo-
ruminants.
Sampling of animal saliva/drool using soft cotton swabs did not cause any harm or discom-
fort or alarm to the animals, and as such the sampling was not subject to ethics application as
defined by the Animal Care and Protection Act 2001 (Queensland) pertaining to agricultural/
domestic animals being sampled non-intrusively by a registered veterinary surgeon (JRW).
Our registered veterinary surgeon (JRW) is an academic employee of the University of Queens-
land, owner of the farm animals, and had permission for access. The domestic animals were
owned by (JRW). Saliva was collected from unrestrained dogs and cats prior to feeding, when
preparation of food and placement into bowls stimulated salivation, which was collected as
drool. Sampling of herbivorous mammals was initially problematic because of contamination
by vegetation. Consequently, saliva from cows was collected as they waited in bales for routine
milking, during which time they do not regurgitate their cud: loading the feeding trough at the
front of the bale with silage stimulated salivation, which was then collected as drool. Saliva
from sheep, horses and the camel was collected using soft cotton oral swabs during scheduled
regular dental examinations, vegetative contamination of horse saliva was overcome by provid-
ing them with a sand yard for one hour prior to sampling. During dental examination sheep
and goats are penned, which discourages cud-chewing. In all cases, sampling of animals
required less than 20 sec, and in no circumstances was an animal restrained solely for the pur-
pose of sampling. Saliva collection was carried out in the animal’s normal day-to-day environ-
ment, with animals that were highly conditioned to the proximity of people.
Saliva was collected from 8 cows (5 of the 8 samples using cotton swabs, 3 collected from
oral drool), 5 sheep (cotton swabs), 7 dogs (cotton swabs), 5 cats (cotton swabs), 5 horses (sam-
ples collected using polystyrene plastic pipettes), 4 goats (cotton swabs), and a single camel
(cotton swab). The animal studies aimed solely to compare the salivary nucleotide metabolites
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patterns to that of human: as no data was available to model the statistical power, sample sizes
were based on the practicality of obtaining saliva samples. The single sample from a camel sym-
bolised a commonality between Saudi Arabia and Australia.
Breastmilk
Ethical permission for the donation of breastmilk was covered by MHS HREC Study Reference
Number 2012_01LNR, with written informed consent being provided by the donor mothers.
Breastmilk samples were collected from 24 mothers, 1 to 5 days postpartum, by a research
nurse using sterile gloves and hand expression into 50 mL sterile containers (Sarstedt Pty Ltd,
Australia). Milk samples were placed on ice without delay and then transferred to the labora-
tory where they were subdivided into portions for the immediate assay of endogenous H2O2,
or for storage at -80°C for further analyses such as XO assays. Pre-term and term 'Aptamil
Gold Plus' (Nutricia Australia Pty Ltd, Australia) infant milk formula and pasteurised breast-
milk were obtained for XO activity assays from the Division of Neonatology, Mater Mothers’
Hospital. Commercial pasteurised bovine milk was purchased fresh from a local retail outlet.
Assay of Hydrogen Peroxide
All H2O2 and linked assays were incubated in flat-bottom microtiter plates (Becton Dickinson,
Australia) at 37°C with shaking, in a temperature-controlled FLUOstar Omega fluorimeter
(BMG Labtech, USA), until the reaction ceased. In the presence of peroxidase, H2O2 reacts
with Ampliflu Red (10-acetyl-3,7-dihydroxyphenoxazine) to produce resorufin, which was
measured fluorimetrically (544 nm excitation, 590 nm emission). ‘Peroxidase reagent’ com-
prised 100 μMAmpliflu Red (Sigma-Aldrich Pty Ltd, Australia) and 0.8 U/mL horseradish
peroxidase (Sigma-Aldrich Pty Ltd, Australia) in 100 mM Tris-HCl buffer pH7.5. The H2O2
concentration was calculated from a standard curve, with calibration of the stock H2O2 con-
centration using absorbance at 240 nm.
To assay endogenous milk H2O2, freshly-expressed untreated breastmilk was immediately
diluted 1:5 (v/v) in 100 mM Tris-HCl buffer pH 7.5. Then 50 μL diluted milk was combined in
a microtiter well with 50 μL ‘peroxidase reagent’, then monitored for 30 min in the fluorimeter.
Assay of generation of H2O2 by a mixture of neonatal saliva with breastmilk, to simulate
suckling, was achieved by mixing 33 μL diluted breastmilk, 33 μL neonatal saliva and 34 μL
peroxidase reagent. Concentrations of hypoxanthine and xanthine in the neonatal saliva sam-
ple were 70 μM and 30 μM respectively. A negative control contained buffer and peroxidase
reagent only (n = 2). Calculation of H2O2 generation was thus based on the assumption that
breastmilk and neonatal saliva mix in the neonate's mouth at an approximate 1:1 ratio during
suckling, and that 1 mole xanthine produces 1 mole H2O2 while 1 mole hypoxanthine gener-
ates 2 moles H2O2.
Xanthine Oxidase and Peroxidase Enzyme Activities
For assay of milk XO activity and kinetic parameters, breastmilk (stored at -80°C) was diluted
1:30 in Tris buffer immediately before assay. Then 50 μL diluted milk was mixed with 50 μL
'peroxidase reagent'. The XO kinetic parameters were estimated for 6 breast milk samples using
hypoxanthine concentrations of 0, 8, 12.5, 25, 50, 100, 200, 300, 400 μM as the final reaction
concentration. XO activity of the remaining milk samples (n = 18) were assayed directly using
only 400 μM hypoxanthine. For each breast milk sample, a corresponding assay substrate
blank (i.e. excluding hypoxanthine) was subtracted from each data point. The production of
H2O2 was monitored for 60 min in the fluorimeter, during the oxidation of hypoxanthine to
uric acid. To confirm H2O2 was produced by XO activity only, the XO-specific inhibitor
Breastmilk-Neonatal Saliva Interactions
PLOS ONE | DOI:10.1371/journal.pone.0135047 September 1, 2015 14 / 19
oxypurinol (Sigma-Aldrich Pty Ltd, Australia) was added to the above assay mix with pooled
breastmilk at a range of final concentrations up to 25 μM. The lower limit for detection of
activity under the conditions of assay was 0.1 U/L, a unit (U) defined as production of l μmol
H2O2 per min. XO activity was also assessed in the infant dried milk formula 'Aptamil Gold
Plus', pasteurised breastmilk and pasteurised bovine milk.
Peroxidase activity in milk is generally attributed to LPO, whereas 'salivary peroxidase'
(SPO) activity is considered to be a mixture of myeloperoxidase and LPO [54]. We did not
attempt to discern these two peroxidases. For assay of peroxidase activity in breastmilk or
saliva, 50 μL breastmilk or saliva was diluted 1:15 in calcium/magnesium-free phosphate-buff-
ered saline (PBS), were mixed with 50 μL 100 μMAmpliflu Red and 200 μMH2O2 in PBS. The
reaction was monitored in the fluorimeter as for XO activity.
Salivary Thiocyanate Assay
Assay of thiocyanate was based on a spectrophotometric method developed for human saliva
using the ferric nitrate method [55], adapted for microtiter plates.
Inhibition of Bacterial Growth by Hydrogen Peroxide
Escherichia coli (ATCC 2592), Staphylococcus aureus (ATCC 29213), Salmonella species
(ATCC 1311) and Lactobacillus plantarum (UQM 297) were obtained from the microbial cul-
ture collection of the Queensland University of Technology (Brisbane, Australia). Bacterial
growth inhibition assays were conducted in sterile flat-bottom 96-microtiter plates (Thermo
Scientific, Australia). To test direct inhibition by H2O2, bacterial stocks were diluted in 'Oxoid
nutrient broth' (Oxoid Pty Ltd, Australia) to a final concentration of 200 colony-forming units
(CFU)/mL, then 50 μL aliquots were added to microtiter plate wells with serial dilutions of
H2O2 in nutrient broth to final concentrations of 400, 200, 100, 50, 25, 12, 6, 3, 1.5, 0.75, 0 μM,
in triplicates. A negative control contained H2O2 and nutrient broth only. Sealed microtiter
plates were incubated at 37°C for 24 h or 48 h with shaking. Bacterial growth was determined
turbidometrically using a microtiter plate reader (xMark, Bio-Rad Laboratories Pty. Ltd., Aus-
tralia) as absorbance at 600 nm. Oxoid nutrient broth, in common with most standard media,
contains significant concentrations of purines and pyrimidines: we found hypoxanthine
(121 μM), xanthine (36 μM), adenosine (19 μM), inosine (148 μM), guanosine (65 μM) and
uridine (87 μM) plus other trace levels of nucleotide metabolites.
Preparation of Simulated Neonatal Saliva
As neonatal saliva was available only in small volumes, 'simulated neonatal saliva' was prepared
by pooling 50 adult salivary samples, collected by passive drooling. This was then heat-inacti-
vated at 56°C in a water bath for 35 min with mixing, to remove antibody activity present in
adult saliva but which is negligible in neonatal saliva [56]. The saliva was then sterilised by vac-
uum filtration through a 0.45 μm filter (Grace Discovery Sciences, Australia) to remove bacte-
ria present in adult saliva as well as particulate matter but not mucins and other proteins. This
resulting 'simulated neonatal saliva' was supplemented with hypoxanthine and xanthine, and/
or inosine, adenosine, guanosine, uracil and uridine (27, 20, 11, 12, 7, 5.3, 12 μM respectively)
with/without 100 μM oxypurinol, to produce four different controls. These nucleoside/base
concentrations corresponded to the median values for the metabolites in neonatal saliva. The
27 μM hypoxanthine plus 20 μM xanthine can theoretically produce 74 μMH2O2 (assuming
XO converts each μmole of hypoxanthine and xanthine to 2 and 1 μmole H2O2 respectively).
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Inhibition or Stimulation of Bacterial Growth by Breastmilk-Saliva
Mixtures
Stock bacteria species as above were diluted in sterile PBS, not nutrient broth. Breastmilk was
diluted 1:6 in sterile Tris buffer. Each microtiter well contained 50 μL of four different simu-
lated neonatal saliva formulations, 25 μL diluted breastmilk, 25 μL bacteria to give a final con-
centration of 200 CFU/mL bacteria in a total volume of 100 μL (in triplicate). The sealed
96-well plates were incubated 24 h at 37°C with mixing. Aliquots were then inoculated onto
agar plates, incubated and viable CFU counted. Serial dilutions of xanthine and hypoxanthine
were also prepared using this assay method. The final concentrations of both xanthine and
hypoxanthine were 0, 6, 25 and 50 μM, which theoretically can produce 0, 18, 75 and 150 μM
H2O2.
Statistical Analyses
The nucleotide metabolite data were not normally distributed (D’Agostino and Pearson omni-
bus normality test), so median values were compared between two different groups using the
Mann-Whitney test and between more than two groups using the Kruskal-Wallis test. The
parameters of the Michaelis-Menten kinetic model, Vmax and Km, for breastmilk XO were esti-
mated using nonlinear regression analysis. All data for XO and bacterial inhibitory studies met
the assumption for normality; therefore mean values were compared between two different
groups using t-test and between more than two groups using one-way ANOVA. A p-value of
0.05 was used as the cut-off for statistical significance.
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